Stem Cell Implantations via retrobulbar injection and IV injection, combined with daily injection of Mouse Nerve Growth Factor and Traditional Chinese Medicine.
Ms. Tarabay is a 58-year-old lady, who’s vision significantly decreased 4 years ago, so much so that it affected her daily routines. She was diagnosed with Optic Nerve Atrophy and sought local medical advice, which was to use some medications to apparently maintain her condition, but no treatment was available to improve her much needed eyesight. In 2019 her left eyesight started to deteriorate even further and Ms. Tarabay became very desperate. Her family urgently searched on the internet for an effective treatment and discovered that there were indeed several hospitals offering treatments. After consulting with the various hospitals and conducting hours of research into the various treatment options, Ms. Tarabay and her family decided to receive treatment at the Beijing Puhua International Hospital, where she was going to receive Stem Cell Treatment for Optic Nerve Atrophy.
Ms. Tarabay’s brithday during the hospitalization, we are celebrating with her.
Treatment Procedure for Optic Nerve Atrophy:
On July 28th 2019, Ms. Tarabay was admitted to Beijing Puhua International Hospital, were she completed all necessary eye examinations. The results confirmed that Optic Nerve Atrophy had reduced her vision, especially in her left eye.
Her suggested treatment plan was confirmed by our Specialists and Ms. Tarabay was going to receive:
2 times Stem Cell Transplantation via Retrobulbar Injection Therapy + 1 time Stem Cell Transplantation via IV; Mouse Growth Factor injections; Traditional Chinese Medicine Treatments and other supporting Therapies.
Medical Condition after Stem Cell Treatment:
Following the treatment, Ms. Tarabay’s vision and visual field were significantly improved. She and her family are very excited about her improved vision and very grateful for the care, compassion and help she received at Beijing Puhua International Hospital.
We are also looking forward to further improvements in Ms. Tarabay’s vision and will follow up with her in the future.
Visual field test before and after the treatment